These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 11569473)
1. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect? Nair S; Saeed O; Shahab H; Sedky K; Garver D; Lippmann S Gen Hosp Psychiatry; 2001; 23(4):231-2. PubMed ID: 11569473 [No Abstract] [Full Text] [Related]
2. Risperidone and dysphagia. Varghese ST; Balhara YP; George SA; Sagar R J Postgrad Med; 2006; 52(4):327-8. PubMed ID: 17102565 [No Abstract] [Full Text] [Related]
4. Neuroleptic-induced dysphagia: case report and literature review. Dziewas R; Warnecke T; Schnabel M; Ritter M; Nabavi DG; Schilling M; Ringelstein EB; Reker T Dysphagia; 2007 Jan; 22(1):63-7. PubMed ID: 17024549 [TBL] [Abstract][Full Text] [Related]
6. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses? Neu C; Dimascio A; Demirgian E Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975 [No Abstract] [Full Text] [Related]
8. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug. Singh MM; Smith JM J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306 [No Abstract] [Full Text] [Related]
9. Re: Extrapyramidal side effects with low-dose risperidone. Pies R Can J Psychiatry; 1997 Oct; 42(8):881. PubMed ID: 9356779 [No Abstract] [Full Text] [Related]
10. A controlled trial of amantadine in drug-induced extrapyramidal disorders. DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE Arch Gen Psychiatry; 1976 May; 33(5):599-602. PubMed ID: 5066 [TBL] [Abstract][Full Text] [Related]
11. Noncompliance with antiparkinsonian medications in neuroleptic-treated schizophrenic patients: three cases of an unreported phenomenon. Bermanzohn PC; Siris SG J Clin Psychiatry; 1994 Nov; 55(11):488-91. PubMed ID: 7989282 [TBL] [Abstract][Full Text] [Related]
12. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980 [TBL] [Abstract][Full Text] [Related]
13. Extrapyramidal syndrome presenting as dysphagia: a case report. Gonzalez F Am J Hosp Palliat Care; 2008; 25(5):398-400. PubMed ID: 19047493 [TBL] [Abstract][Full Text] [Related]
14. Dysphagia associated with risperidone therapy. Stewart JT Dysphagia; 2003; 18(4):274-5. PubMed ID: 14571332 [TBL] [Abstract][Full Text] [Related]
15. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis. Swett C; Cole JO; Shapiro S; Slone D Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418 [TBL] [Abstract][Full Text] [Related]
16. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone. Windhaber J; Urbanits S; Grisold W Neurology; 2000 Apr; 54(7):1543-4. PubMed ID: 10751282 [No Abstract] [Full Text] [Related]